Evidence map›Paper›PMID 35570858›Full record

ArticleRadiology case reports2022

Asymptomatic gangrenous cholecystitis diagnosed using contrast-enhanced ultrasonography in a patient with pancreatic cancer.

Ryo Katsumata, Noriaki Manabe, Takashi Urano, Tomohiro Tanikawa, Katsunori Ishii, Maki Ayaki, Minoru Fujita, Mitsuhiko Suehiro, Hideyo Fujiwara, Yasumasa Monobe and 5 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Ryo KatsumataDepartment of General Internal Medicine 2, Kawasaki Medical School General Medical Center, Okayama, Japan.
Noriaki ManabeDepartment of Clinical Pathology and Laboratory Medicine, Kawasaki Medical School General Medical Center, 2-6-1 Nakasange Kita-ku, Okayama City, Okayama 700-8505, Japan.
Takashi UranoDepartment of General Surgery, Kawasaki Medical School General Medical Center, 2-6-1 Nakasange Kita-ku, Okayama City, Okayama 700-8505, Japan.
Tomohiro TanikawaDepartment of General Internal Medicine 2, Kawasaki Medical School General Medical Center, Okayama, Japan.
Katsunori IshiiDepartment of General Internal Medicine 2, Kawasaki Medical School General Medical Center, Okayama, Japan.
Maki AyakiDepartment of Clinical Pathology and Laboratory Medicine, Kawasaki Medical School General Medical Center, 2-6-1 Nakasange Kita-ku, Okayama City, Okayama 700-8505, Japan.
Minoru FujitaDepartment of Clinical Pathology and Laboratory Medicine, Kawasaki Medical School General Medical Center, 2-6-1 Nakasange Kita-ku, Okayama City, Okayama 700-8505, Japan.
Mitsuhiko SuehiroDepartment of General Internal Medicine 2, Kawasaki Medical School General Medical Center, Okayama, Japan.
Hideyo FujiwaraDepartment of Pathology, Kawasaki Medical School General Medical Center, 2-6-1 Nakasange Kita-ku, Okayama City, Okayama 700-8505, Japan.
Yasumasa MonobeDepartment of Pathology, Kawasaki Medical School General Medical Center, 2-6-1 Nakasange Kita-ku, Okayama City, Okayama 700-8505, Japan.
Tomoari KamadaDepartment of Health Care Medicine, Kawasaki Medical School General Medical Center, 2-6-1 Nakasange Kita-ku, Okayama City, Okayama 700-8505, Japan.
Tomoki YamatsujiDepartment of General Surgery, Kawasaki Medical School General Medical Center, 2-6-1 Nakasange Kita-ku, Okayama City, Okayama 700-8505, Japan.
Yoshio NaomotoDepartment of General Surgery, Kawasaki Medical School General Medical Center, 2-6-1 Nakasange Kita-ku, Okayama City, Okayama 700-8505, Japan.
Ken HarumaDepartment of General Internal Medicine 2, Kawasaki Medical School General Medical Center, Okayama, Japan.
Hirofumi KawamotoDepartment of General Internal Medicine 2, Kawasaki Medical School General Medical Center, Okayama, Japan.
Kawasaki Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 72-year-old female without abdominal symptoms visited our hospital for routine follow-up while undergoing pancreatic cancer treatment (using TS-1). Her vital signs were normal, and her abdomen was soft and non-tender. Blood test revealed elevated C-reactive protein levels with normal white blood cell count. Computed tomography was performed for follow-up of pancreatic cancer. Contrast-enhanced computed tomography showed partial discontinuity and irregular thickness of the gallbladder wall; however, a definitive diagnosis was not obtained due to unclear imaging. Contrast-enhanced transabdominal ultrasonography revealed intraluminal membranes in the gallbladder and a perfusion defect at the bottom, indicating gangrenous cholecystitis. Surgical resection was performed, and pathological examination showed severe necrosis of the gallbladder wall, consistent with the findings of contrast-enhanced transabdominal ultrasonography.

Indexed as

Asymptomatic diseasesGallbladderGangrenous cholecystitisTransabdominal ultrasonography

Identifiers

PMID35570858
PMCPMC9095665
OpenAlexW4229070860

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.